Cite
APA Citation
Sahin, I. H., Tan, E., & Kim, R. (2021). regorafenib, an investigational agent for the treatment of cholangiocarcinoma. Expert opinion on investigational drugs, 30, 333–341. http://access.bl.uk/ark:/81055/vdc_100129517884.0x000034